Bumrungrad

Bumrungrad Hospital Public Company Limited (BH) has reported its 1Q19 consolidated financial statement through the Stock Exchange of Thailand as follows: BH recorded total revenues in 1Q19 of THB 4,733 million, increased 0.8% from 1Q18 revenues of THB 4,694 million. Its net profit in 1Q19 increased by 0.2% to THB 1,081 million from THB 1,079 million in 1Q18, with Net profit margin at 22.8% in 1Q19, compared to 23.0% in 1Q18. BH reported cost of hospital operations (including Depreciation and amortization) of THB 2,495 million for 1Q19, or 2.2% less year-over-year from THB 2,553 million in 1Q18. This represents a favorable change when compared to the 0.6% increase in revenues from hospital operations, and contributed to a reduction in the percentage of cost to revenues from hospital operations to 53.7% in 1Q19 compared with 55.2% in 1Q18. Selling expenses (including Depreciation and amortization) were THB 115 million in 1Q19, or 46.6% more year-over-year from THB 78 million in 1Q18. EBITDA decreased by 1.2% year-over-year to Baht 1,621 million in 1Q19 from Baht 1,640 million in 1Q18, with an EBITDA margin of 34.5% in 1Q19 compared to 35.2% in 1Q18.